Monarch Capital Management Inc Abbott Laboratories Transaction History

Monarch Capital Management Inc

$365 Million
Q3 2024

A detailed history of Monarch Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Monarch Capital Management Inc holds 56,164 shares of ABT stock, worth $6.29 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

56,164

Previous 55,447 1.29%

Holding current value

$6.29 Million

Previous $5.76 Million 11.14%

% of portfolio

1.75%

Previous 1.72%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$100.07 - $118.13 $71,750 - $84,699	717 Added 1.29%	56,164 $6.4 Million
Q2 2024 Jul 24, 2024	SELL	$100.73 - $112.44 $70,511 - $78,708	-700 Reduced 1.25%	55,447 $5.76 Million
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $31,322 - $34,594	-286 Reduced 0.51%	56,147 $6.38 Million
Q4 2023 Jan 17, 2024	SELL	$90.19 - $110.4 $127,799 - $156,436	-1,417 Reduced 2.45%	56,433 $6.21 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $4,776 - $5,731	-50 Reduced 0.09%	57,850 $5.6 Million
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $43,839 - $48,846	-435 Reduced 0.75%	57,900 $6.31 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $140,931 - $165,884	-1,455 Reduced 2.43%	58,335 $5.91 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $219,113 - $257,053	-2,305 Reduced 3.71%	59,790 $0
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $244,222 - $282,763	-2,524 Reduced 3.91%	62,095 $6.01 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $8,573 - $10,363	84 Added 0.13%	64,619 $7.02 Million
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $52,335 - $63,819	-459 Reduced 0.71%	64,535 $7.64 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $224,936 - $275,422	-1,947 Reduced 2.91%	64,994 $9.15 Million
Q3 2021 Nov 04, 2021	BUY	$116.66 - $129.06 $45,730 - $50,591	392 Added 0.59%	66,941 $7.91 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $59,242 - $69,736	560 Added 0.85%	66,549 $7.72 Million
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $415,442 - $489,453	-3,817 Reduced 5.47%	65,989 $7.91 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $190,680 - $207,786	-1,816 Reduced 2.54%	69,806 $7.64 Million
Q3 2020 Oct 22, 2020	SELL	$91.64 - $111.29 $135,352 - $164,375	-1,477 Reduced 2.02%	71,622 $7.8 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $236,448 - $302,624	-3,088 Reduced 4.05%	73,099 $6.68 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $189,779 - $277,509	-3,021 Reduced 3.81%	76,187 $6.01 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $208,601 - $232,221	-2,657 Reduced 3.25%	79,208 $6.88 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $111,875 - $121,307	-1,367 Reduced 1.64%	81,865 $6.85 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $48,100 - $56,100	-660 Reduced 0.79%	83,232 $7 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $137,671 - $166,444	-2,079 Reduced 2.42%	83,892 $6.71 Million
Q4 2018 Jan 23, 2019	SELL	$65.56 - $74.27 $195,041 - $220,953	-2,975 Reduced 3.34%	85,971 $6.22 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $379,332 - $457,619	-6,238 Reduced 6.55%	88,946 $6.53 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $117,673 - $129,875	-2,044 Reduced 2.1%	95,184 $5.81 Million
Q1 2018 Apr 18, 2018	SELL	$56.27 - $63.62 $59,983 - $67,818	-1,066 Reduced 1.08%	97,228 $5.83 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $329,648 - $352,923	-6,141 Reduced 5.88%	98,294 $5.61 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $5.02 Million - $5.6 Million	104,435	104,435 $5.57 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $196B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.

Account

Monarch Capital Management Inc Abbott Laboratories Transaction History